Media Summary: This presentation provided key principles for comparative analyses (CA) and established understanding of essential CA ... Lisa Bercu, Regulatory Counsel in the Office of Generic 00:25 Relevant definitions 1:15 The Importance of Use Related Risk Analysis 2:41 Human Factors Engineering at different ...

Fda Pmsr Drug Device Combination Implementation Guide - Detailed Analysis & Overview

This presentation provided key principles for comparative analyses (CA) and established understanding of essential CA ... Lisa Bercu, Regulatory Counsel in the Office of Generic 00:25 Relevant definitions 1:15 The Importance of Use Related Risk Analysis 2:41 Human Factors Engineering at different ... Melissa Burns, from the Office of The Commissioner's Office of John Barlow “Barr” Weiner, associate director for policy and product classification in This video provides a simple, step-by-step approach to the

This presentation will include a short summary of the types of Stacey Bruzzese welcomes back Alan Golden from Design Quality Consultants. Stacey and Alan have a conversation about ... Get In Touch with a Regulatory Expert: ... For more information, visit the Oracle Help Center. KEY LEARNING OBJECTIVES - Understand what constitutes a We welcome you to join fellow perfusionists to hear from Catherine Wentz, M.S. from the U.S. Food &

An effective complaint handling process is essential for ensuring patient safety, maintaining product quality, and staying compliant ...

Photo Gallery

FDA PMSR Drug Device Combination Implementation Guide
AGDD 2024 | D1S14 - Drug-Device Combination Products – A New Methodology for Evaluation
What Constitutes Complex Drug-Device Combination (18of35) Complex Generics – Sep. 25-26, 2019
Simplifying the 2023 FDA Guidance on Human Factors Engineering Principles for Combination Products
REdI 2024 | D1S09 - Combination Products: Updates and Best Practices
Combination Products: Reporting Device Information and Malfunctions - Pharmacovigilance 2020
Combination Products: User-interface & Role of Comparative Analyses (29of39) Complex Generics 2018
CGMPs for Combination Products: Understanding and Applying FDA’s Draft Guidance - Barr Weiner of FDA
FDA Human Factors Guidance Simplified
Role of the Product Jurisdiction Team in the Medical Product Development Process
US Drug Delivery Combination Product Regulatory
Design Control for Pharmaceutical Combination Products
View Detailed Profile
FDA PMSR Drug Device Combination Implementation Guide

FDA PMSR Drug Device Combination Implementation Guide

Webinar on

AGDD 2024 | D1S14 - Drug-Device Combination Products – A New Methodology for Evaluation

AGDD 2024 | D1S14 - Drug-Device Combination Products – A New Methodology for Evaluation

This presentation provided key principles for comparative analyses (CA) and established understanding of essential CA ...

What Constitutes Complex Drug-Device Combination (18of35) Complex Generics – Sep. 25-26, 2019

What Constitutes Complex Drug-Device Combination (18of35) Complex Generics – Sep. 25-26, 2019

Lisa Bercu, Regulatory Counsel in the Office of Generic

Simplifying the 2023 FDA Guidance on Human Factors Engineering Principles for Combination Products

Simplifying the 2023 FDA Guidance on Human Factors Engineering Principles for Combination Products

00:25 Relevant definitions 1:15 The Importance of Use Related Risk Analysis 2:41 Human Factors Engineering at different ...

REdI 2024 | D1S09 - Combination Products: Updates and Best Practices

REdI 2024 | D1S09 - Combination Products: Updates and Best Practices

This video provided an overview of

Combination Products: Reporting Device Information and Malfunctions - Pharmacovigilance 2020

Combination Products: Reporting Device Information and Malfunctions - Pharmacovigilance 2020

Melissa Burns, from the Office of The Commissioner's Office of

Combination Products: User-interface & Role of Comparative Analyses (29of39) Complex Generics 2018

Combination Products: User-interface & Role of Comparative Analyses (29of39) Complex Generics 2018

CDER Office of Generic

CGMPs for Combination Products: Understanding and Applying FDA’s Draft Guidance - Barr Weiner of FDA

CGMPs for Combination Products: Understanding and Applying FDA’s Draft Guidance - Barr Weiner of FDA

John Barlow “Barr” Weiner, associate director for policy and product classification in

FDA Human Factors Guidance Simplified

FDA Human Factors Guidance Simplified

This video provides a simple, step-by-step approach to the

Role of the Product Jurisdiction Team in the Medical Product Development Process

Role of the Product Jurisdiction Team in the Medical Product Development Process

Kristina Lauritsen, PhD, CDER

US Drug Delivery Combination Product Regulatory

US Drug Delivery Combination Product Regulatory

This presentation will include a short summary of the types of

Design Control for Pharmaceutical Combination Products

Design Control for Pharmaceutical Combination Products

Stacey Bruzzese welcomes back Alan Golden from Design Quality Consultants. Stacey and Alan have a conversation about ...

Introduction to U.S. FDA Medical Device Regulations

Introduction to U.S. FDA Medical Device Regulations

Get In Touch with a Regulatory Expert: ...

Fulfill Your FDA Combination Product Reporting Requirements

Fulfill Your FDA Combination Product Reporting Requirements

For more information, visit the Oracle Help Center. https://docs.oracle.com/en/industries/health-sciences/index.html.

Frequently Asked Questions about Combination Products

Frequently Asked Questions about Combination Products

KEY LEARNING OBJECTIVES - Understand what constitutes a

FDA Regulation of Medical Devices - Abridged and Simplified

FDA Regulation of Medical Devices - Abridged and Simplified

We welcome you to join fellow perfusionists to hear from Catherine Wentz, M.S. from the U.S. Food &

Developing and Maintaining an FDA Compliant Complaint Handling Process

Developing and Maintaining an FDA Compliant Complaint Handling Process

An effective complaint handling process is essential for ensuring patient safety, maintaining product quality, and staying compliant ...

Drug device combination products   Lise Vanderkelen

Drug device combination products Lise Vanderkelen

When Playing with

CDER - REdI Annual Conference 2026: Innovative Regulatory Strategies to Advance Medical Products

CDER - REdI Annual Conference 2026: Innovative Regulatory Strategies to Advance Medical Products

Learn directly from the

FDA Predetermined Change Control Plan (PCCP) Guidance for Artificial  Intelligence (AI)

FDA Predetermined Change Control Plan (PCCP) Guidance for Artificial Intelligence (AI)

We recorded a new video summarizing the